Methanogen Vaccine Components for Inhibiting Microbial Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively inhibit methane production in ruminants, primarily due to the lack of specific molecules targeting methanogen cells, which are responsible for methane emissions in agricultural settings, posing environmental and economic challenges.
Innovation Solution
Isolation and utilization of peptides, polypeptides, and polynucleotides from Methanobrevibacter ruminantium, specifically cell-surface components, along with expression vectors, host cells, and antibodies, to develop vaccines and compositions that target and inhibit methanogen cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to inhibit methane production, then methane emissions can be reduced, but the methods lack specificity and effectiveness against methanogen cells
Solution Approach 1:
The patent uses antibodies as intermediary molecules that specifically bind to cell-surface components of methanogen cells. These antibodies act as mediators between the vaccine composition and the target methanogens, enabling selective inhibition of methane production without affecting other rumen microbes. The antibodies bridge the gap between the administered vaccine and the harmful methanogen cells, providing both specificity and effectiveness.
Solution Approach 2:
The invention extracts and utilizes specific cell-surface components from methanogen cells as antigenic determinants for vaccine development. By taking out these specific surface components (peptides, polypeptides) from the whole cell, the vaccine can specifically target methanogens without requiring broad-spectrum agents, thereby achieving both effectiveness and specificity simultaneously.
2Object-generated harmful factors
If vaccines targeting methanogen cell-surface components are developed, then specific inhibition of methanogens can be achieved, but the complexity of identifying and producing these specific components increases
Solution Approach 1:
The patent employs cloning techniques to create multiple copies of the genes encoding specific methanogen cell-surface components. By copying these genetic sequences into expression vectors and host cells, the system can produce large quantities of the specific antigenic peptides and polypeptides needed for vaccine formulation, thereby reducing the practical complexity of production while maintaining high specificity.
Solution Approach 2:
The invention segments the complex task of methanogen targeting into identifiable molecular components - specifically isolating and characterizing individual cell-surface proteins and their encoding genes. This segmentation allows each component to be independently studied, cloned, and produced, simplifying the overall vaccine development process while maintaining specificity for methanogen cells.
3Productivity
If methanogen inhibition is achieved through vaccination, then methane emissions are reduced and ruminant productivity improves, but the identification of effective targets requires extensive research
Solution Approach 1:
The patent utilizes molecular probing techniques that detect and measure cell-surface components of methanogens through specific binding interactions. By using labeled antibodies or probes that bind to target antigens, researchers can detect and measure the presence and quantity of specific methanogen surface components, thereby simplifying target identification and validation processes.
Solution Approach 2:
The invention performs preliminary characterization and identification of methanogen cell-surface components before vaccine formulation. By pre-identifying and isolating specific surface proteins and their genes, the research community has established a foundation of known targets that can be directly used for vaccine development, thereby reducing the overall difficulty and time required for target identification in future studies.
Data Source
AI summary
The invention encompasses components from microbial cells which are useful for antibody production, including peptides, polypeptides comprising these peptides, polynucleotides which encode these peptides or polypeptides, and antibodies directed to these peptides, polypeptides, or polynucleotides. The invention also encompasses to expression vectors and host cells for producing these peptides, polypeptides, polynucleotides, and antibodies. The invention further encompasses methods and compositions, especially vaccine compositions, for detecting, targeting, and inhibiting microbial cells, especially methanogen cells, using one or more of the disclosed peptides, polypeptides, polynucleotides, antibodies, expression vectors, and host cells.